1. Home
  2. FLGT vs FDUS Comparison

FLGT vs FDUS Comparison

Compare FLGT & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • FDUS
  • Stock Information
  • Founded
  • FLGT 2011
  • FDUS 2011
  • Country
  • FLGT United States
  • FDUS United States
  • Employees
  • FLGT N/A
  • FDUS N/A
  • Industry
  • FLGT Medical Specialities
  • FDUS Finance/Investors Services
  • Sector
  • FLGT Health Care
  • FDUS Finance
  • Exchange
  • FLGT Nasdaq
  • FDUS Nasdaq
  • Market Cap
  • FLGT 697.3M
  • FDUS 745.8M
  • IPO Year
  • FLGT 2016
  • FDUS 2011
  • Fundamental
  • Price
  • FLGT $23.00
  • FDUS $20.39
  • Analyst Decision
  • FLGT Buy
  • FDUS Buy
  • Analyst Count
  • FLGT 3
  • FDUS 3
  • Target Price
  • FLGT $25.33
  • FDUS $21.67
  • AVG Volume (30 Days)
  • FLGT 228.6K
  • FDUS 268.0K
  • Earning Date
  • FLGT 11-07-2025
  • FDUS 10-30-2025
  • Dividend Yield
  • FLGT N/A
  • FDUS 11.09%
  • EPS Growth
  • FLGT N/A
  • FDUS N/A
  • EPS
  • FLGT N/A
  • FDUS 2.31
  • Revenue
  • FLGT $303,223,000.00
  • FDUS $152,305,000.00
  • Revenue This Year
  • FLGT $15.19
  • FDUS $6.31
  • Revenue Next Year
  • FLGT $10.58
  • FDUS $5.37
  • P/E Ratio
  • FLGT N/A
  • FDUS $8.81
  • Revenue Growth
  • FLGT 4.31
  • FDUS 8.16
  • 52 Week Low
  • FLGT $14.57
  • FDUS $16.70
  • 52 Week High
  • FLGT $23.57
  • FDUS $23.55
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 60.31
  • FDUS 39.09
  • Support Level
  • FLGT $22.05
  • FDUS $20.05
  • Resistance Level
  • FLGT $23.57
  • FDUS $20.50
  • Average True Range (ATR)
  • FLGT 0.68
  • FDUS 0.34
  • MACD
  • FLGT 0.02
  • FDUS -0.02
  • Stochastic Oscillator
  • FLGT 74.94
  • FDUS 25.40

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About FDUS Fidus Investment Corporation

Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.

Share on Social Networks: